🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open-label,multicenter Phase II study for evaluating...
Status
Unknown
Location
Multiple Locations
Start Date
2019-03-01
Trial ID
NCT03847818
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a randomized, double-blind multicenter Phase III study for evaluati...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2019-08-01
Trial ID
NCT03756064
Treatments Being Tested
This is a randomized, open label Phase II-III neoadjuvant study comparing t...
Status
Active Not Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2022-05-23
Trial ID
NCT05426486
Treatments Being Tested
Due to neoadjuvant therapy with trastuzumab and pertuzumab is less effectiv...
Status
Unknown
Location
the First Affiliated Hospital of Nanjing Medical University
Start Date
2023-04-15
Trial ID
NCT05430347
Treatments Being Tested
This is an investigator-initiated randomized controlled, open-label, multic...
Status
Recruiting
Location
Shengjing Hospital of China Medical University
Start Date
2022-12-20
Trial ID
NCT05638594
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Completed
Location
Henan cancer hospital
Start Date
2018-11-20
Trial ID
NCT03735966
Treatments Being Tested
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested
This study is a phase III clinical trial to explore the efficacy and safety...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-16
Trial ID
NCT07239271